EXECUTIVE ENGAGEMENTS
POOL
2833
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
512
Interactions with Platform & by Email
PARTICIPANTS
83
Unique # Participated
VALIDATIONS
24
Responses Validated*
COMPANIES
42
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
159
PAGES
231
EDITION
7
PRICE
USD 4950
CODE
MCP15286
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for RNA Analysis / Transcriptomics estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$11.8 Billion by 2027, growing at a CAGR of 14.1% over the analysis period 2020-2027.Reagents / Consumables, one of the segments analyzed in the report, is projected to grow at a 15.4% CAGR to reach US$5.9 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 12.5% CAGR for the next 7-year period. This segment currently accounts for a 30.1% share of the global RNA Analysis / Transcriptomics market.
The RNA Analysis / Transcriptomics market in the U.S. is estimated at US$1.8 Billion in the year 2020. The country currently accounts for a 39.34% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1 Billion in the year 2027 trailing a CAGR of 15.6% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.9% and 14.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR while Rest of European market (as defined in the study) will reach US$1 Billion by the year 2027.
In the global Services segment, USA, Canada, Japan, China and Europe will drive the 14.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$744.8 Million in the year 2020 will reach a projected size of US$1.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$737.3 Million by the year 2027.
SELECT PLAYERS
Affymetrix, Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Fluidigm Corporation; GE Healthcare; Illumina, Inc.; MilliporeSigma; Qiagen NV; Thermo Fisher Scientific, Inc.
SEGMENTS
» Product (Reagents / Consumables, Instruments, Services, Software) » Technology (Polymerase Chain Reaction, Sequencing, Microarray, RNA Interference) » Application (Drug Discovery, Toxicogenomics, Clinical Diagnostics, Comparative Transcriptomics)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Transcriptomics Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Transcriptomics Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Transcriptomics Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Microarray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Polymerase chain reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Polymerase chain reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Polymerase chain reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Sequencing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Sequencing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Sequencing Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Pharmaceutical and biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Pharmaceutical and biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Pharmaceutical and biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Academic Research and Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic Research and Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic Research and Government Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Transcriptomics Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Transcriptomics Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Transcriptomics Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 42 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com